Scalable AAV production in single use bioreactors

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

Production of high titer AAV at clinical scales remains a challenge for the gene therapy industry. Developers need to understand how to optimize, scale, and qualify their manufacturing process for AAV production under the tightest of time lines.

Due to high demand in the gene therapy space, effective solutions to address these challenges must be developed and implemented.

This month, Jon Zmuda (Director, Cell Biology, Thermo Fisher Scientific) will discuss how to meet the needs of this fast-moving industry. He will conduct a special Q&A to answer any questions on the demand webinars below and any other AAV production, purification, and process-related questions.

As a webinar attendee, you will learn about:

• Enabling scalable, high-titer AAV production in single use bioreactors
• How to optimize recovery and purity in downstream processing
• Robust and efficient AAV production workflows

Watch: Complete system for AAV production for clinical production: Part 1 - Upstream

Watch: Optimizing vector production and purification to enhance scalable AAV manufacturing

Jon Zmuda

Director, Cell Biology Thermo Fisher Scientific

Jonathan Zmuda, Ph.D. is a Director of Cell Biology R&D within the Biosciences Division of Thermo Fisher Scientific located in Frederick, MD (USA). Within Cell Biology, Jon leads various teams that focus on developing new technologies for protein expression, viral vector production, transfection and classical cell culture. Dr. Zmuda received his Ph.D. in Cell Biology from the University of Maryland, College Park and his undergraduate degree from Dickinson College in Carlisle, PA.

Watch now

SPEAKERS

Jon Zmuda

Director, Cell Biology Thermo Fisher Scientific

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual

27 June

in 69

Days

Register

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe

29 May

in 40

Days

Register

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz

23 May

in 34

Days

Register

T cells from beginning to end: optimizing leukopak and drug product cryopreservation

Meredith Safford, ShaNelle Yelity

22 May

in 33

Days

Register

Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Emily Jackson-Holmes

21 May

in 32

Days

Register